Modified Zinc Monoglycerolate Nucleating Agent for Polyolefins
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current nucleating agents for polyolefins, such as zinc monoglycerolate, are costly and less effective at low loadings, necessitating the development of more efficient and cost-effective nucleating agents that can enhance polymer crystallization temperature and cycle time reduction in injection molding.
Innovation Solution
A modified form of zinc monoglycerolate (GMS-ZMG) is produced using a new process involving zinc oxide and a glycerol monostearate modifier, resulting in smaller crystallite sizes and improved agglomerate structure, which enhances nucleating efficiency at lower loadings.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If unmodified zinc monoglycerolate is used as a nucleating agent, then the nucleating effect is achieved, but the cost per kilogram of polymer is high and the efficacy at low loadings is insufficient
Solution Approach 1:
The patent modifies the crystallite size parameter of zinc monoglycerolate by controlling the average coherence domain length to be no more than 30 nm in the c-direction and no more than 60 nm in the a-direction. This parameter change enables the nucleating agent to achieve superior efficacy at significantly lower loadings compared to unmodified zinc monoglycerolate, directly resolving the contradiction between quantity of substance and reliability.
Solution Approach 2:
The patent creates a composite structure by combining zinc monoglycerolate with specific crystallite size control mechanisms, resulting in a modified nucleating agent (GMS-ZMG) that achieves enhanced performance at low loadings. The composite approach integrates the base material with structural control to overcome the limitations of unmodified zinc monoglycerolate.
2Temperature
If higher loadings of nucleating agent are used to improve nucleating effect, then the crystallization temperature increases, but the cost increases and the loading level becomes less efficient
Solution Approach 1:
By optimizing the crystallite size parameters (c-direction ≤30 nm, a-direction ≤60 nm), the patent achieves enhanced nucleating effect at lower loadings, allowing the same crystallization temperature improvement to be achieved with reduced quantity of substance, thus resolving the contradiction between temperature improvement and quantity required.
3Manufacturing precision
If conventional zinc monoglycerolate production processes are used, then the nucleating agent is produced, but the crystallite size is larger and the nucleating efficiency at low loadings is reduced
Solution Approach 1:
The patent implements precise control over crystallite size parameters during production, achieving average coherence domain lengths of no more than 30 nm in the c-direction and no more than 60 nm in the a-direction. This manufacturing precision directly enhances nucleating efficiency at low loadings, resolving the contradiction between manufacturing precision and productivity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
GMS-ZMG achieves higher crystallization temperatures and faster crystallization times in polyolefins at significantly lower loadings compared to unmodified zinc monoglycerolate, offering improved cost-effectiveness and performance.
Implementation Method 1
the degree of polymer crystallinity is generally controlled by use of appropriate levels of nucleating agents. These nucleating agents confer advantages to the polymer by raising the crystallisation temperature (Tc) of the polymer, increasing the crystallisation kinetics
Implementation Method 2
GMS-ZMG achieves higher crystallization temperatures and faster crystallization times in polyolefins at significantly lower loadings compared to unmodified zinc monoglycerolate
Data Source
AI summary
A method of manufacture of zinc monoglycerolate containing an incorporated modifier, and the product, the zinc monoglycerolate being in the form of agglomerates of crystallites, wherein the crystallite size based on the average coherence domain length is not more than 30 nm in the <100> direction, and not more than 60 nm in the <011> direction, as determined by the Scherrer equation via powder X-ray diffraction; and the aspect ratio computed by <100>/<011> coherent domain lengths is less than 0.65, preferably less than 0.56, in particular less than 0.44. Polymers containing this nucleating agent and methods for their production are also described. The zinc monoglycerolate is useful as a nucleating agent, and is very effective at low loading levels in polymers such as polypropylene.